Tenaya Therapeutics (TNYA) EBITDA Margin (2026)
Tenaya Therapeutics (TNYA) recorded quarterly EBITDA Margin of 8565.33% in Q1 2026.
Tenaya Therapeutics (TNYA) EBITDA Margin (2026) Analysis & Trends
Tenaya Therapeutics' EBITDA Margin history runs 1 years deep, the most recent figure standing at 8565.33% for Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Tenaya Therapeutics | 158.32 Mn | 158.32 Mn | - | -8,565.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8,565.33% |